Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
August 14, 2002

Teva Has Recalled Clonazepam Tablets

(SafetyAlerts) - The Food and Drug Administration (FDA) has released the following information.

PRODUCT
a) Clonazepam Tablets, USP 1 mg, 100, 500, and 1,000 count bottles, Rx only. Recall # D-372-2;
b) Clonazepam Tablets, USP 2 mg, 100 and 500 count bottles, Rx only. Recall # D-373-2.

CODE
a) Lot numbers for 1 mg strength:
356546 exp. 11/30/03, 356547 exp. 11/30/03, 356548 exp. 11/30/03, 356549 exp. 11/30/03, 356550 exp. 11/30/03, 356551 exp. 11/30/03, 356552 exp. 11/30/03, 356553 exp. 11/30/03, 356554 exp. 11/30/03, 356555 exp. 11/30/03, 356556 exp. 11/30/03, 356557 exp. 11/30/03, 356558 exp. 11/30/03, 356559 exp. 11/30/03, 356560 exp. 11/30/03, 356561 exp. 11/30/03, 356562 exp. 11/30/03, 356563 exp. 11/30/03, 356564 exp. 11/30/03, and 356565 exp. 11/30/03.
b) Lot numbers for 2 mg strength:
355108 exp. 11/30/03, 355109 exp. 11/30/03, and
355110 exp. 11/30/03.

RECALLING FIRM/MANUFACTURER
Recalling Firm: Teva Pharmaceuticals USA, Sellersville, PA, by letters on June 10, 2002.
Manufacturer: Teva Pharmaceuticals, Jerusalem, Israel.
Firm initiated recall is ongoing.

REASON
Tablet mix up: 2 mg tablets may be in bottles labeled as containing 1 mg tablets and/or 1 mg tablets may be in bottles labeled as containing 2mg tablets.

VOLUME OF PRODUCT IN COMMERCE
160,391 bottles.

DISTRIBUTION
Nationwide
.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.